1887

n South African Medical Journal - South African ischaemic stroke guideline, 2010 : correspondence

USD

 

Abstract

We believe the guideline by Bryer et al. to be overdue and well constructed, and generally to contain excellent recommendations. However, the authors note that intravenous tissue plasminogen activator (tPA) 'is an accepted therapy' and 'significantly improves outcome'; particular reference is made to the ECASS III trial to justify its use within 4.5 hours of stroke onset. We believe that this is a dangerous and unsupported recommendation.

Loading

Article metrics loading...

/content/m_samj/101/1/EJC67411
2011-01-01
2016-12-03
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error